Analysis of gene expression during the first 10 weeks following PEG-interferon-alfa2B/ribavirin treatment of a group of hepatitis C raments

被引：0
|
作者：
Taylor, Milton W.
Tsukahara, Takurna
Kwo, Paul
机构：
[1] Indiana Univ, Bloomington, IN USA
[2] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
283
引用
收藏
页码：365A / 365A
页数：1
相关论文
共 50 条
  • [11] Peg-interferon alfa-2b and Ribavirin for the treatment of genotype 1 hepatitis C recurrence after liver transplantation
    Lodato, F.
    Berardi, S.
    Gramenzi, A.
    Mazzella, G.
    Lenzi, M.
    Morelli, M. C.
    Tame, Mr.
    Piscaglia, F.
    Andreone, P.
    Ballardini, G.
    Bernardi, M.
    Bianchi, F. B.
    Biselli, M.
    Bolondi, L.
    Cescon, M.
    Colecchia, A.
    D'Errico, A.
    Del Gaudio, M.
    Ercolani, G.
    Grazi, G. L.
    Grigioni, W.
    Lorenzini, S.
    Pinna, A. D.
    Ravaioli, M.
    Roda, E.
    Sama, C.
    Vivarelli, M.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A36 - A36
  • [12] Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia - Reply
    Pozzato, G
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 738 - 738
  • [13] PEG-Interferon α-2b+ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b+ribavirin therapy.
    Sulkowski, M
    Rothstein, K
    Stein, L
    Godofsky, E
    Goodman, R
    Dieterich, D
    GASTROENTEROLOGY, 2003, 124 (04) : A783 - A783
  • [14] Interferon ALFA-2B (IFN-a2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 234 - 234
  • [15] Gene expression of cytoplasmic viral sensors and regulators involving innate immunity and resistance to PEG-interferon alfa-2B plus ribavirin treatment in chronic hepatitis C
    Asahina, Yasuhiro
    Izumi, Namiki
    Hirayama, Itsuko
    Sato, Mitsuaki
    Tanaka, Tomohiro
    Komatsu, Nobutoshi
    Umeda, Naoki
    Hosokawa, Takanori
    Ueda, Ken
    Nakanishi, Hiroyuki
    Tsuchiya, Kaoru
    Itakura, Jun
    Kurosaki, Masayuki
    Uchihara, Masakatsu
    Miyake, Shozo
    HEPATOLOGY, 2007, 46 (04) : 345A - 345A
  • [16] Gene expression profiles of patients with chronic hepatitis C (CH-C) treated with pegylated interferon alfa-2b and ribavirin (PEG-IFN/RBV)
    Younossi, ZM
    Chan, J
    Schlauch, K
    Assmann, J
    Santini, C
    Ong, J
    Martin, L
    Gramlich, T
    McAllister, L
    Chang, SY
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A720
  • [17] ENDOGENOUS ERYTHROPOIETIN RESPONSE AND PREDICTIVE FACTORS FOR ANEMIA DURING TREATMENT WITH PEG-INTERFERON ALFA-2B AND RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS
    van Vlerken, L. G.
    van Soest, H.
    Janssen, M. P.
    Boland, G. J.
    Drenth, J. P. H.
    Burger, D. M.
    Siersema, P. D.
    van Erpecum, K. J.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S103 - S103
  • [18] Endogenous Erythropoietin Response and Predictive Factors for Anemia During Treatment With PEG-Interferon Alfa-2B and Ribavirin in Chronic Hepatitis C Patients
    van Vlerken, Lotte G.
    van Soest, Hanneke
    Janssen, Mart P.
    Boland, Greet J.
    Drenth, Joost P. H.
    Burger, David M.
    Siersema, Peter D.
    Van Erpecum, Karel J.
    GASTROENTEROLOGY, 2010, 138 (05) : S842 - S842
  • [19] PEG-Interferon alfa-2b plus Ribavirin-Behandlung bei chronischer Hepatitis C
    Monatsschrift Kinderheilkunde, 2005, 153 (12) : 1192 - 1193
  • [20] Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: A case report and review of the literature
    Cacopardo B.
    Benanti F.
    Pinzone M.R.
    Nunnari G.
    BMC Research Notes, 6 (1)
12345